Vitamin Shoppe (VSI) Tops Q2 EPS by 26c, Revenues Beat

Vitamin Shoppe (NYSE: VSI) reported Q2 EPS of $0.31, $0.26 better than the analyst estimate of $0.05. Revenue for the quarter came in at $293.1 million versus the consensus estimate of $283.4 million.

Commenting on the Company\'s financial performance, Bill Wafford, Chief Financial Officer said, "The Company delivered improved financial results primarily attributable to growth from digital commerce and better gross margins. Additionally, the excess cash flow generated in the quarter, coupled with a draw down on our line of credit, enabled us to opportunistically repurchase $30 million face value of our convertible debt due December 2020 at a discount to par value. To date, we have repurchased $75 million face value of our convertible debt, further improving our financial position."

Alex Smith, Chairman of the Vitamin Shoppe stated, "Our focus on retail fundamentals is starting to deliver improved performance. In the second quarter we saw improvement across all key metrics including: comp sales, customer acquisition and product margin. Additionally, as we announced on July 23rd, Sharon Leite will be our new CEO. I am delighted to have a leader of Sharon\'s caliber to spearhead the ongoing turnaround and future growth, building on the recent good work of the organization."

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• CoreWeave (CRWV) Reiterated at Neutral by DA Davidson Amid Rising Cost of Capital
• AMC Networks (AMCX) PT Raised to $10 at UBS on Higher Cash Generation, Visibility